What is Braxia Scientific Corp. (BRAX.CN)?

Braxia Scientific Corp. (BRAX.CN) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

Braxia Scientific Corp. (BRAX.CN)

Stock analysis · CNQ · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.44

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Braxia Scientific Corp. (BRAX.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Braxia Scientific Corp.

Braxia Scientific Corp. is a medical research enterprise that runs clinics specializing in ketamine-based treatments for individuals facing depression and related conditions. The company further operates a network of multidisciplinary clinics dedicated to addressing a wide spectrum of mental health disorders. Beyond its clinical services, Braxia is actively engaged in research and development, striving to discover and commercialize novel pharmaceutical compounds and advanced delivery systems. Utilizing its intellectual property development platform, it focuses on the creation and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products. The firm's corporate headquarters are located in Toronto, Ontario.